Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Non-cash Items (2018 - 2024)

Historic Non-cash Items for OptimizeRx (OPRX) over the last 10 years, with Q4 2024 value amounting to $813397.0.

  • OptimizeRx's Non-cash Items fell 2223.74% to $813397.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $813397.0, marking a year-over-year decrease of 2223.74%. This contributed to the annual value of $813397.0 for FY2024, which is 2223.74% down from last year.
  • OptimizeRx's Non-cash Items amounted to $813397.0 in Q4 2024, which was down 2223.74% from $4.1 million recorded in Q3 2024.
  • In the past 5 years, OptimizeRx's Non-cash Items ranged from a high of $4.1 million in Q3 2024 and a low of $26410.0 during Q1 2021
  • Over the past 5 years, OptimizeRx's median Non-cash Items value was $929698.5 (recorded in 2023), while the average stood at $1.2 million.
  • Per our database at Business Quant, OptimizeRx's Non-cash Items tumbled by 9580.74% in 2020 and then tumbled by 2223.74% in 2024.
  • Quarter analysis of 5 years shows OptimizeRx's Non-cash Items stood at $1.5 million in 2020, then crashed by 94.93% to $78334.0 in 2021, then skyrocketed by 1863.07% to $1.5 million in 2022, then plummeted by 31.98% to $1.0 million in 2023, then fell by 22.24% to $813397.0 in 2024.
  • Its Non-cash Items was $813397.0 in Q4 2024, compared to $4.1 million in Q3 2024 and $492000.0 in Q1 2024.